any studies of sex-related differences in the shortand long-term outcomes of acute myocardial infarction (AMI) have concluded that mortality is higher among women than men. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] The reason for poorer outcomes in women remains unclear. The higher mortality among women may be partially explained by the fact that women were older than men and had higher rates of unfavorable prognostic factors in previous studies. After the adjustment for these factors, however, several studies continued to show a survival disadvantage for women. 2, 3, 5, 8 The persistence of higher mortality after risk adjustment may be because women usually receive less aggressive treatment for AMI than men. 2, 3, 8, 11 However, analyses adjusting for baseline differences between women and men have yielded conflicting results. Several studies have found that sex is an independent risk factor for increased mortality after AMI, 1,4 whereas others have not. 6, 7, 12 Another potential explanation for the higher mortality among women is delayed presentation to the hospital. 13, 14 In general, women with AMI present to the hospital later than men, suggesting different behavioral responses. Women have been reported to be less likely than men to believe that they are having a heart attack when they experience symptoms of AMI. 15 Several studies have reported that women have different or less typical symptoms of AMI than men. 14, 16, 17 Women are more likely to have non-chest pain, nausea or vomiting (or both), and shortness of breath. 14,17-20 These atypical symptoms may make it difficult for not only women with AMI, but also bystanders and health-care providers to correctly interpret the situation and take appropriate action. An important limitation of previous studies examining sexrelated differences in symptom presentation among patients with AMI was their retrospective design. Patients were interviewed by many different physicians, without the use of a standardized interview form. The results of interviews were thus subject to bias. More importantly, studies of sex-related differences in symptoms at the onset of AMI are lacking in Japan.
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To examine sex-related differences in the clinical features of ST-segment elevation AMI in Japan, we prospectively studied a series of men and women who were admitted to the coronary care unit of our Medical Center. In this pilot study, the same cardiologist interviewed all patients within 48 h after admission to minimize interview-related bias.
Methods

Study Group
From January 2001 through December 2004, 510 consecutive patients with ST-segment elevation AMI were admitted to our coronary care unit within 24 h after symp- , and a typical increase in serum creatine kinase to more than twice the upper limit of normal. We studied 457 patients (351 men and 106 women) in whom a detailed clinical history was obtained within 48 h after admission. Their mean (± SD) age was 65±12 years (range, 31 to 93 years). Fiftythree patients were excluded from the study because of cardiogenic shock (n=25), dementia (n=8), early death (n=2), or other conditions precluding the assessment of pain within 48 h after admission (n=18). All patients gave informed consent. The study protocol was approved by our Internal Review Boards.
Pain Assessment
Patients were interviewed and asked to describe the features and location of pain at the onset of AMI and any other relevant symptoms. All interviews were conducted by the same cardiologist within 48 h after admission. For analysis, pain and other symptoms were classified according to the following locations: (1) jaw; (2) throat, neck; (3) anterior chest; (4) left shoulder; (5) left arm, forearm, and/or hand; (6) right shoulder; (7) right arm, forearm, and/or hand; (8) epigastric region; and (9) back. All regions with pain were evaluated.
Pain was qualitatively classified into the following 5 types: (1) a squeezed feeling; (2) a compressed or pressed down feeling; (3) a burning or searing feeling; (4) a burst open or split feeling; and (5) others (non-specific symptoms, such as a vague distressed feeling, throbbing or tingling pain, or a strange feeling as if your body was not your own). The severity of pain was classified according to the following 4 levels (the most severe pain was evaluated): very severe (associated with the fear of death); severe (collapsing on the floor and unable to move); moderate (not too severe to move and able to start moving after temporary cessation); and mild (able to continue to move without any problem). Patients were also asked whether AMI was associated with any of the following symptoms: cold sweating, nausea, vomiting, or shortness of breath.
Coronary Angiography
Coronary angiography was performed immediately after admission in 425 patients (93%). The perfusion status of the infarct-related artery was assessed according to the criteria of the Thrombolysis in Myocardial Infarction (TIMI) study. 21 The recanalization method was left to the discretion of the patients' physicians. The final TIMI flow grade was assessed on the basis of final angiograms obtained on admission. Stenosis was considered clinically significant if there was a narrowing of the luminal diameter by ≥75% in any projection.
Cardiac-Enzyme Measurements
Blood samples were obtained on admission, at 3-h intervals during the first 24 h after admission, at 6-h intervals for the next 2 days, and then daily until discharge.
Statistical Analysis
Data are expressed as mean ± SD. The statistical significance of differences between men and women was evaluated with the use of unpaired t-tests. Differences in prevalence were assessed with the use of chi-square tests. A p value of <0.05 was considered to indicate statistical significance. Analyses were conducted with SPSS-PC software, version 11.0 (SPSS, Chicago, IL, USA). 
Results
Baseline Characteristics
Of the 457 patients studied, 351 (77%) were men and 106 (23%) were women. The baseline characteristics of the subjects are shown according to sex in Table 1 . Overall, the women were older than the men and were more likely to have a lower body-mass index, diabetes mellitus, hyperlipidemia, and hypertension. Women were less likely to have a history of smoking. Hemodynamic variables on admission and the rates of previous infarction, percutaneous coronary intervention, and coronary-artery bypass graft surgery did not differ between the sexes. Before the onset of AMI, aspirin, calcium-channel blockers, and 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors were more frequently used by women than by men. The peak creatine kinase level was significantly lower in women than in men.
Features of Infarction Pain
The features of infarction pain are shown in Table 2 . Women were more likely than men to have non-specific symptoms, non-chest pain such as pain in the jaw, throat, neck, shoulder, arm, and back, and mild pain. As for concomitant symptoms, women were more likely to have nausea, but less likely to have cold sweating than men. The rates of vomiting and shortness of breath were slightly but not significantly higher in women than in men.
Angiographic Findings
Angiographic findings of the patients are shown in Table 3 . There were no significant differences in the rates of emergency coronary angiography, recanalization therapy, or the number or distribution of diseased coronary vessels, including 3-vessel disease and left main coronary artery disease, between women and men. The initial and final TIMI flow grades also did not differ between the sexes. The rates of percutaneous coronary intervention and coronary-artery bypass graft surgery during hospitalization were similar in women and men.
In-Hospital Outcomes
During hospitalization (mean, 14 days), 12 patients (2.6%) died: 7 women (5 of cardiac rupture and 2 of heart failure) and 5 men (3 of heart failure, 1 of infection, and 1 of stroke). In-hospital mortality was significantly higher in women than in men. The 5 women who died of cardiac rupture during hospitalization were elderly (mean age, 85 years) and had high rates of hypertension and anterior myocardial infarction. In addition, 2 patients did not receive and 1 patient did not respond to reperfusion therapy (Table 4 ).
Discussion
Our study confirms and extends previous findings that women with AMI tend to be older than men with AMI and are more likely to have cardiac risk factors (except smoking) as well as less typical symptoms of AMI, such as non-specific symptoms, non-chest pain (pain in the jaw, neck, arm, or back), nausea, vomiting, and shortness of breath. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [16] [17] [18] [19] [20] The extent of underlying coronary atherosclerosis did not differ between women and men. Most of the women (74%) underwent percutaneous coronary interventions, similar to men. The baseline and postprocedural TIMI flow grades in women were similar to those in men. However, the in-hospital mortality rate was significantly higher in women than in men.
These inherent biologic distinctions between women and men may account for the poorer outcomes of AMI in the former. Interestingly, before the onset of AMI, a higher proportion of women than men were receiving drugs considered to prevent cardiovascular disease, such as aspirin and HMG CoA reductase inhibitors.
Non-chest pain, nausea, vomiting, and shortness of breath have been reported to be more common in women with AMI. [17] [18] [19] [20] Although our results support this finding, the frequencies of these symptoms were generally higher in our study than in previous investigations, perhaps because our patients were interviewed more carefully. It is unclear why women had many atypical symptoms. Culic et al have reported that diabetes mellitus and advanced age are associated with atypical signs and symptoms of AMI. 22 Many women in the present study were elderly and had diabetes mellitus, possibly contributing to the higher rate of atypical symptoms. Less typical symptoms of AMI may be considered inconsistent with AMI and mistakenly attributed to musculoskeletal, gastrointestinal, or neurologic diseases. Moreover, we found that women were more likely than men to have mild pain at the onset of AMI, thereby prolonging the time to hospital admission. The severity of acute chest pain has been found to be unrelated to increased mortality in patients with pain. 23 Patients and clinicians must recognize that women with AMI are more likely to have less typical symptoms of AMI, such as non-specific symptoms, non-chest pain, mild pain, nausea, vomiting, and shortness of breath.
Women are significantly less likely than men to receive thrombolytic therapy, percutaneous transluminal coronary angioplasty, and coronary-artery bypass grafting. 2, 3, 8, 11, 24 However, most of our patients received percutaneous coronary intervention; possible effects of treatment bias on mortality are therefore considered minimal. As for coronary angiographic findings, the extent of underlying coronary atherosclerosis and the baseline and postprocedural TIMI flow grades were similar in women and men, consistent with the findings of prior investigations. 1, 6, 25, 26 Previous studies have shown that women are more likely than men to have cardiogenic shock. 1, 27 We excluded patients with cardiogenic shock because a detailed medical history could not be obtained. Nonetheless, the in-hospital mortality rate in women was approximately 5 times higher than that in men. In the present study, the primary cause of inhospital mortality among women was cardiac rupture. Yip et al found that risk factors for cardiac rupture after AMI included older age, female sex, and a lower body mass index. 28 They reported that early successful direct percuta- 
Study Limitations
This study was performed at a single center and included a relatively small number of patients with ST-segment elevation AMI in whom a detailed medical history was obtained. To minimize bias, however, the same cardiologist prospectively interviewed all subjects to establish the types and intensities of symptoms caused by AMI. We therefore believe that our results are less biased than those of previous studies in which several different cardiologists assessed patients' medical histories.
Implications
Previous studies have examined sex-related differences in symptoms or outcomes of AMI. [14] [15] [16] [17] [18] [19] [20] To the best of our knowledge, however, this is the first study of sex-related differences in the clinical characteristics of ST-segment elevation AMI in which all patients were interviewed by a single investigator to minimize interview-related bias. The poorer outcome of AMI in women may be related to several factors. Our study confirmed that men and women with AMI have different basic biologic characteristics (age, body-mass index, concurrent disease), as well as different symptoms and behavioral responses at the onset of AMI. Further prospective studies involving larger numbers of patients are required to further assess the effects of these differences on clinical outcomes. Women with AMI should receive earlier, more aggressive treatment. We believe that the role of health-care professionals in educating patients to promptly recognize and respond to possible cardiac symptoms is essential for improved survival after AMI, especially in women.
